|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/29/16 Mimedx Group, Inc. 10-K 12/31/15 84:7.4M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 787K
2: EX-21.1 Subsidiaries List HTML 22K
3: EX-23.1 Consent of Experts or Counsel HTML 24K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 25K
14: R1 Document and Entity Information HTML 51K
15: R2 Consolidated Balance Sheets HTML 100K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K
17: R4 Consolidated Statements of Operations HTML 75K
18: R5 Consolidated Statements of Stockholders' Equity HTML 106K
19: R6 Consolidated Statements of Stockholders' Equity HTML 27K
(Parenthetical)
20: R7 Consolidated Statements of Cash Flows HTML 108K
21: R8 Nature of Business HTML 28K
22: R9 Significant Accounting Policies HTML 66K
23: R10 Liquidity and Capital Resources HTML 28K
24: R11 Cash Equivalents and Short Term Investments HTML 26K
25: R12 Inventories HTML 37K
26: R13 Investments HTML 25K
27: R14 Property and Equipment HTML 41K
28: R15 Intangible Assets and Royalty Agreement HTML 63K
29: R16 Long-Term Debt HTML 33K
30: R17 Net Income (loss) Per Share HTML 50K
31: R18 Common Stock Placements HTML 32K
32: R19 Equity HTML 138K
33: R20 Income Taxes HTML 92K
34: R21 Supplemental Disclosure of Cash Flow and Non-Cash HTML 54K
Investing and Financing Activities
35: R22 401k Plan HTML 29K
36: R23 Commitments and Contingencies HTML 63K
37: R24 Quarterly Financial Data (Unaudited) HTML 93K
38: R25 Subsequent Events HTML 28K
39: R26 Schedule II - Valuation and Qualifying Accounts HTML 71K
40: R27 Significant Accounting Policies (Policies) HTML 129K
41: R28 Inventories (Tables) HTML 36K
42: R29 Property and Equipment (Tables) HTML 38K
43: R30 Intangible Assets and Royalty Agreement (Tables) HTML 63K
44: R31 Net Income (loss) Per Share (Tables) HTML 51K
45: R32 Equity (Tables) HTML 137K
46: R33 Income Taxes (Tables) HTML 86K
47: R34 Supplemental Disclosure of Cash Flow and Non-Cash HTML 53K
Investing and Financing Activities (Tables)
48: R35 Commitments and Contingencies (Tables) HTML 31K
49: R36 Quarterly Financial Data (Unaudited) (Tables) HTML 91K
50: R37 Nature of Business (Details) HTML 25K
51: R38 Significant Accounting Policies (Details) HTML 65K
52: R39 Liquidity and Capital Resources (Details) HTML 46K
53: R40 Cash Equivalents and Short Term Investments HTML 33K
(Details)
54: R41 Inventories (Details) HTML 37K
55: R42 Investments (Details) HTML 27K
56: R43 Property and Equipment (Details) HTML 51K
57: R44 Intangible Assets and Royalty Agreement Intangible HTML 88K
Asssets Activity Summary (Details)
58: R45 Intangible Assets and Royalty Agreement Expected HTML 39K
Future Amortization of Intangible Assets (Details)
59: R46 Long-Term Debt (Details) HTML 79K
60: R47 Net Income (loss) Per Share Computation of Basic HTML 50K
and Dilutive Net Loss per Share (Details)
61: R48 Net Income (loss) Per Share Summary of HTML 35K
Antidilutive Securities (Details)
62: R49 Common Stock Placements (Details) HTML 33K
63: R50 Equity Narrative (Details) HTML 83K
64: R51 Equity Activity of Stock Options (Details) HTML 78K
65: R52 Equity Exercise Price Ranges (Details) HTML 75K
66: R53 Equity Summary of Unvested Stock Options (Details) HTML 43K
67: R54 Equity Assumptions (Details) HTML 40K
68: R55 Equity Summary of Restricted Stock Awards HTML 48K
(Details)
69: R56 Equity Recognized Stock-Based Compensation HTML 33K
(Details)
70: R57 Income Taxes Deferred Tax Assets and Liabilities HTML 51K
(Details)
71: R58 Income Taxes Reconciliation of the Federal HTML 47K
Statutory Income Tax (Details)
72: R59 Income Taxes Schedule of current and deferred HTML 49K
income tax expense (Benefit) (Details)
73: R60 Income Taxes Reconciliation of unrecognized tax HTML 28K
benefits (Details)
74: R61 Income Taxes Narrative (Details) HTML 50K
75: R62 Supplemental Disclosure of Cash Flow and Non-Cash HTML 61K
Investing and Financing Activities (Details)
76: R63 401k Plan (Details) HTML 36K
77: R64 Commitments and Contingencies Estimated Annual HTML 34K
Lease, Royalty, and Employment Agreement Expenses
(Details)
78: R65 Commitments and Contingencies Narrative (Details) HTML 65K
79: R66 Quarterly Financial Data (Unaudited) (Details) HTML 46K
80: R67 Subsequent Events (Details) HTML 42K
81: R68 Schedule II - Valuation and Qualifying Accounts HTML 40K
(Details)
83: XML IDEA XML File -- Filing Summary XML 142K
82: EXCEL IDEA Workbook of Financial Reports XLSX 93K
8: EX-101.INS XBRL Instance -- mdxg-20151231 XML 1.89M
10: EX-101.CAL XBRL Calculations -- mdxg-20151231_cal XML 205K
11: EX-101.DEF XBRL Definitions -- mdxg-20151231_def XML 539K
12: EX-101.LAB XBRL Labels -- mdxg-20151231_lab XML 1.71M
13: EX-101.PRE XBRL Presentations -- mdxg-20151231_pre XML 937K
9: EX-101.SCH XBRL Schema -- mdxg-20151231 XSD 149K
84: ZIP XBRL Zipped Folder -- 0001376339-16-000138-xbrl Zip 224K
| Exhibit |
1. | I have reviewed this annual report on Form 10-K of MiMedx Group, Inc.; |
2. | Based on my knowledge,
this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this annual report is being prepared, |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, |
(c) | evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation, and |
(d) | disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent
function): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
/s/: Michael J. Senken | ||
Michael J. Senken | ||
Chief
Financial Officer | ||
(principal financial officer) | ||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/29/16 | 4 | ||
| For Period end: | 12/31/15 | 10-K/A, 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/25/17 SEC UPLOAD¶ 9/28/17 1:41K Mimedx Group, Inc. 1/09/17 SEC UPLOAD¶ 9/28/17 1:41K Mimedx Group, Inc. 12/06/16 SEC UPLOAD¶ 9/28/17 1:139K Mimedx Group, Inc. 10/31/16 SEC UPLOAD¶ 9/28/17 1:169K Mimedx Group, Inc. |